Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Accurate expert analysis for a fragmented market

timely news deep insight pharma intelligence

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

See how we can help you get ahead in the competitive medtech environment: watch the video

Relevant products

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

Real-time news and analysis
Regulatory development news
Company development news

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

Real-time market intelligence
Medical device market coverage
Discover new opportunities

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

In Vivo

A Tale Of Two Pipelines

By Dennis Chang; Keith Flaherty; Uciane Scarlett 29 Jan 2020

Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.

Topic Cancer Research

View analysis
In Vivo

ESG In 2020: Not A Tick-Box Exercise But A Strategic Opportunity

By William Looney 29 Jan 2020

The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.

View article
Medtech Insight

CES 2020: Panel Discusses Health Care In 2040 – Empowered Consumer, Digital Transformation, Data Sharing, Open Source

By Marion Webb 29 Jan 2020

An expert panel at CES 2020 discussed Deloitte's vision for health care in 2040, with the empowered consumer managing their own health, enabled by a new ecosystem of secure, open access to data and "nudges" to change behaviors. Consulting firm Deloitte foresees outside disruptors dismantling the traditional health-care system, but panelists from Johnson & Johnson and Anthem flexed their muscles.

Topic Business Strategies Digital Health

View analysis
Medtech Insight

MDSAP And USMCA: 3 Ways Mexico Can To Come Up-To-Speed With The Single-Audit Program Targeted By New Free-Trade Accord

By Shawn M. Schmitt 29 Jan 2020

The US-Mexico-Canada (USMCA) treaty calls for the three countries to “recognize audits” performed under the Medical Device Single Audit Program. MDSAP is already used by device makers in the US and Canada so they can undergo one audit by an accredited third party to satisfy quality regulations. That leaves Mexico as the odd country out when it comes to using the popular program – and that means it has some catching up to do after the USMCA is ratified by all three nations. Former longtime FDA official Kim Trautman weighs in on how Mexico can incorporate MDSAP into its regulatory framework.

View analysis
In Vivo

Bayer US Pharmaceuticals' Sebastian Guth: Designs On A New Decade

By William Looney 27 Jan 2020

Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.

View article
Medtech Insight

Medicinal Products Expert And Established Devices Leader Head Commission's Medtech Unit

By Amanda Maxwell 27 Jan 2020

Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.

View article
Medtech Insight

Diagnostics Sector On High Alert As Wuhan Coronavirus Spreads

By Brian Yang 27 Jan 2020

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, diagnostics companies are rushing to have test kits ready.

View article
Medtech Insight

Compliance Corner: The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm (Part 1)

By Shawn M. Schmitt 15 Jan 2020

A panel of longtime industry experts offer manufacturers a list of things they should and shouldn’t do when an investigator from the US agency knocks on their facility door. In this first installment of a 10-part series, a procedure for hosting inspections is addressed.

View analysis
Medtech Insight

Exec Chat: CES 2020: For FDA's Amy Abernethy It's About Data, But Also Community Engagement

By Marion Webb 15 Jan 2020

Amy Abernethy, FDA's principal deputy commissioner, sat down with Medtech Insight during CES 2020 to discuss the agency's progress on the Technology Modernization Action Plan, the pre-certification program for digital health products, and the FDA's plans for 2020.

Topic Digital Health FDA

View analysis
Medtech Insight

Execs On The Move: Two Top Appointments At RTI Surgical; A CEO Promotion At Guerbet

08 Jan 2020

RTI Surgical, a surgical implants company, hired a global spine president and an original equipment manufacturer products president; Guerbet, a maker of medical-imaging products, promoted its chief commercial officer to CEO; and more.

View article
Medtech Insight

FDA Will Keep Listening To Patient-Engagement Experts

By Ferdous Al-Faruque 08 Jan 2020

The US agency says in a 6 January Federal Register notice that it’s keeping its Patient Engagement Advisory Committee in place through October 2021 so it can gather more patient feedback that will come in handy when regulatory decisions need to be made. The committee, formed after the agency made a cultural shift to consider patient input on the types of products it allows on the market, was supposed to expire October 2019.

View article
Medtech Insight

Official: European Parliament Signs Off Council of EU's 4 Extra Years For Class I Upclassified Devices

By Amanda Maxwell 18 Dec 2019

Medtech industry gets best seasonal gift as Council of EU and European Parliament agree on longer transition period for upclassified Class I medical devices. But how many notified bodies are still auditing products under the medical device directives?

View article
Medtech Insight

FDA Proposes End To Quarterly Reporting On HDE, PMA Decisions

By Elizabeth Orr 18 Dec 2019

A proposal from the US FDA would end quarterly publication of PMA and Humanitarian Device Exemption verdicts in the Federal Register. The agency says the practice is inefficient and duplicates online publication.

View article
In Vivo

Outlook 2020 Report

18 Dec 2019

Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.

Single report
Medtech Insight

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

By Ashley Yeo 11 Dec 2019

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.

View analysis